One Global Service Provider Limited

BOM-514330
Bombay Stock Exchange
Health Services
Global Rank
#28893
Country Rank
#1820
Market Cap
62.22 M
Price
3.18
Change (%)
0.62%
Volume
47,553

One Global Service Provider Limited's latest marketcap:

62.22 M

As of 09/26/2025, One Global Service Provider Limited's market capitalization has reached $62.22 M. According to our data, One Global Service Provider Limited is the 28893th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 62.22 M
Revenue (ttm) 25.04 M
Net Income (ttm) 2.99 M
Shares Out 19.54 M
EPS (ttm) 0.13
Forward PE 0.00
Ex-Dividend Date 09/23/2024
Earnings Date 08/11/2025
Market Cap Chart
Data Updated: 09/26/2025

One Global Service Provider Limited's yearly market capitalization.

One Global Service Provider Limited has seen its market value grow from ₹48.74 M to ₹5.52 B since 2015, representing a total increase of 11,223.63% and an annual compound growth rate (CAGR) of 62.51%.
Date Market Cap(₹) Market Cap(USD) Change (%) Global Rank
09/26/2025 ₹5.52 B $62.22 M 132.91% 28893
12/31/2024 ₹2.35 B $27.51 M 709.6% 32050
12/29/2023 ₹290.87 M $3.5 M 17.98% 40600
12/30/2022 ₹246.53 M $2.98 M 66.03% 39520
12/31/2021 ₹148.49 M $1.99 M 1061.11% 38786
12/31/2020 ₹12.79 M $174,946.31 -57.14% 36985
12/31/2019 ₹29.84 M $418,055.16 -30% 34032
12/28/2018 ₹42.63 M $612,567.84 -18.26% 32579
12/29/2017 ₹52.15 M $816,646.28 -6.5% 31155
12/20/2016 ₹55.77 M $820,405.38 14.43% 29111

Company Profile

About One Global Service Provider Limited

One Global Service Provider Limited is a global leader in life sciences and healthcare solutions, offering a comprehensive range of diagnostic, laboratory, and IT services. Headquartered in Mumbai, India, the company has been serving clients worldwide since its incorporation in 1992 (formerly known as Overseas Synthetics Limited).

Core Services

  • Diagnostic Services: Amenia, antenatal, diabetes monitoring, hypertension, kidney and lipid profiles, and liver function tests.
  • Healthcare Solutions: Industrial occupational check-ups, population screening for non-communicable diseases, disease surveillance programs, electronic medical records, health analytics, and wellness programs.
  • Laboratory Services: Biochemistry, microbiology, hematology, histopathology, clinical pathology, molecular diagnostics, and serology.
  • Healthcare Products: Medical devices, equipment, consumables, and reagents available via an online platform.
  • Home-Based Care: Health screening, remote care services, and public health data analytics for hospitals, professionals, and government bodies.

IT Services

The company provides end-to-end IT consultancy and development, including:

  • Software/IT product development (design, testing, deployment, and maintenance).
  • Solutions for e-commerce, banking, healthcare, education, retail, telecommunications, and more.

With a strong focus on innovation and quality, One Global Service Provider Limited continues to expand its footprint in the healthcare and technology sectors.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.